Staar Surgical Stock Performance
| STAA Stock | USD 29.10 0.92 3.26% |
The entity owns a Beta (Systematic Risk) of 1.58, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, STAAR Surgical will likely underperform. At this point, STAAR Surgical has a negative expected return of -0.16%. Please make sure to validate STAAR Surgical's information ratio, skewness, day typical price, as well as the relationship between the treynor ratio and daily balance of power , to decide if STAAR Surgical performance from the past will be repeated at future time.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days STAAR Surgical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
Actual Historical Performance (%)
One Day Return 0.43 | Five Day Return 5.98 | Year To Date Return (5.21) | Ten Year Return 222.43 | All Time Return 81.81 |
Last Split Factor 1:2 | Last Split Date 1992-05-18 |
1 | Staar Surgical Co Stock Price Down 3.29 percent on Sep 20 | 09/20/2024 |
2 | From Capitol to Classroom Texans Deserve World-Class Public Education, and Teachers Need Competitive Wages and Compensation | 09/30/2024 |
3 | Acquisition by Patrick Williams of 24460 shares of STAAR Surgical subject to Rule 16b-3 | 10/16/2024 |
4 | Sangamo Therapeutics Announces Alignment With FDA on Accelerated Approval Pathway for ST-920 in Fabry Disease With BLA Submission Expected in 2025 | 10/22/2024 |
5 | STAAR Surgical Reports Third Quarter 2024 Results | 10/30/2024 |
6 | Deutsche Bank cuts Kraft Heinz rating following Q3 results | 10/31/2024 |
7 | A Dive into Staar Surgical International Revenue Trends and Forecasts | 11/04/2024 |
8 | Staar Surgical Co Stock Price Down 3.98 percent on Nov 12 | 11/12/2024 |
9 | STAAR Surgical to Participate in Stephens Annual Investment Conference | 11/13/2024 |
10 | Staar Surgical Co Shares Down 2.96 percent on Nov 26 | 11/26/2024 |
| Begin Period Cash Flow | 86.5 M |
STAAR |
STAAR Surgical Relative Risk vs. Return Landscape
If you would invest 3,232 in STAAR Surgical on August 31, 2024 and sell it today you would lose (414.00) from holding STAAR Surgical or give up 12.81% of portfolio value over 90 days. STAAR Surgical is currently does not generate positive expected returns and assumes 3.3512% risk (volatility on return distribution) over the 90 days horizon. In different words, 29% of stocks are less volatile than STAAR, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
STAAR Surgical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for STAAR Surgical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as STAAR Surgical, and traders can use it to determine the average amount a STAAR Surgical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0486
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | STAA |
Estimated Market Risk
| 3.35 actual daily | 29 71% of assets are more volatile |
Expected Return
| -0.16 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average STAAR Surgical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of STAAR Surgical by adding STAAR Surgical to a well-diversified portfolio.
STAAR Surgical Fundamentals Growth
STAAR Stock prices reflect investors' perceptions of the future prospects and financial health of STAAR Surgical, and STAAR Surgical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on STAAR Stock performance.
| Return On Equity | 0.054 | ||||
| Return On Asset | 0.0339 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 1.19 B | ||||
| Shares Outstanding | 49.28 M | ||||
| Price To Earning | 460.83 X | ||||
| Price To Book | 3.24 X | ||||
| Price To Sales | 4.07 X | ||||
| Revenue | 322.42 M | ||||
| Gross Profit | 223.38 M | ||||
| EBITDA | 34.83 M | ||||
| Net Income | 21.35 M | ||||
| Cash And Equivalents | 202.49 M | ||||
| Cash Per Share | 4.22 X | ||||
| Total Debt | 35.83 M | ||||
| Debt To Equity | 0.10 % | ||||
| Current Ratio | 6.37 X | ||||
| Book Value Per Share | 8.69 X | ||||
| Cash Flow From Operations | 14.59 M | ||||
| Earnings Per Share | 0.44 X | ||||
| Market Capitalization | 1.39 B | ||||
| Total Asset | 488.69 M | ||||
| Retained Earnings | (47.37 M) | ||||
| Working Capital | 300.23 M | ||||
| Current Asset | 49.07 M | ||||
| Current Liabilities | 17.89 M | ||||
About STAAR Surgical Performance
By analyzing STAAR Surgical's fundamental ratios, stakeholders can gain valuable insights into STAAR Surgical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if STAAR Surgical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if STAAR Surgical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 121.64 | 115.55 | |
| Return On Tangible Assets | 0.08 | 0.08 | |
| Return On Capital Employed | 0.11 | 0.12 | |
| Return On Assets | 0.08 | 0.08 | |
| Return On Equity | 0.11 | 0.11 |
Things to note about STAAR Surgical performance evaluation
Checking the ongoing alerts about STAAR Surgical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for STAAR Surgical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| STAAR Surgical generated a negative expected return over the last 90 days | |
| STAAR Surgical has high historical volatility and very poor performance | |
| STAAR Surgical is unlikely to experience financial distress in the next 2 years | |
| STAAR Surgical has a strong financial position based on the latest SEC filings | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Staar Surgical Co Shares Down 2.96 percent on Nov 26 |
- Analyzing STAAR Surgical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether STAAR Surgical's stock is overvalued or undervalued compared to its peers.
- Examining STAAR Surgical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating STAAR Surgical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of STAAR Surgical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of STAAR Surgical's stock. These opinions can provide insight into STAAR Surgical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for STAAR Stock analysis
When running STAAR Surgical's price analysis, check to measure STAAR Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy STAAR Surgical is operating at the current time. Most of STAAR Surgical's value examination focuses on studying past and present price action to predict the probability of STAAR Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move STAAR Surgical's price. Additionally, you may evaluate how the addition of STAAR Surgical to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |